Chronic Lymphocytic Leukemia / edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky
Contributor(s): Hallek, Michael., editor literario | Eichhorst, Barbara., editor literario | Catovsky, Daniel., editor literario | SpringerLink (Online service)
Material type:
E-bookSeries: (Hematologic Malignancies, 2197-9766); (Medicine (Springer-11650)).Publisher: Cham : Springer International Publishing, 2019Description: 1 recurso en línea (VI, 179 páginas) : 23 ilustraciones, 19 ilustraciones a color.ISBN: 9783030113926.Subject: Leucemia linfática crónica
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC643 2019 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook09072338 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC643 2017 EB Acute Myeloid Leukemia : Methods and Protocols | RC643 2018 EB Chronic Lymphocytic Leukemia: Pathobiology, B Cell Receptors, Novel Mutations, Clonal Evolution | RC643 2018 EB Acute Promyelocytic Leukemia : A Clinical Guide | RC643 2019 EB Chronic Lymphocytic Leukemia | RC643 2019 EB Leukemia stem cells in hematologic malignancies | RC643 2021 EB Epigenetics and Proteomics of Leukemia . A Synergy of Experimental Biology and Computational Informatics | RC643 2021 EB Acute Myeloid Leukemia |
Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed. .
There are no comments on this title.